{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:30:07Z","timestamp":1789403407699,"version":"build-2803163510"},"reference-count":161,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1053\/j.seminoncol.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T15:00:35Z","timestamp":1403708435000},"page":"478-495","source":"Crossref","is-referenced-by-count":13,"title":["Multimodal Magnetic Resonance Imaging Evaluation of Primary Brain Tumors"],"prefix":"10.1053","volume":"41","author":[{"given":"Daniel","family":"Treister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E.","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Shiroishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpneuro0289","article-title":"Epidemiology and molecular pathology of glioma","volume":"2","author":"Schwartzbaum","year":"2006","journal-title":"Nature clinical practice Neurology"},{"issue":"Suppl 5","key":"10.1053\/j.seminoncol.2014.06.006_bib2","first-page":"v1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neurooncology"},{"issue":"17","key":"10.1053\/j.seminoncol.2014.06.006_bib3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nurt.2009.05.001","article-title":"Molecular epidemiology of primary brain tumors","volume":"6","author":"Gu","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11910-007-0031-5","article-title":"Update on the management of familial central nervous system tumor syndromes","volume":"7","author":"Hottinger","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7 Suppl","key":"10.1053\/j.seminoncol.2014.06.006_bib6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cncr.23741","article-title":"Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium","volume":"113","author":"Bondy","year":"2008","journal-title":"Cancer"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","article-title":"Genome-wide association study identifies five susceptibility loci for glioma","volume":"41","author":"Shete","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib8","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/1078-0432.CCR-0659-03","article-title":"Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas","volume":"10","author":"Xie","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000218165","article-title":"Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas","volume":"77","author":"Argyriou","year":"2009","journal-title":"Oncology"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nature reviews Cancer"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"\u2018Pseudopalisading\u2019 necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"10.1053\/j.seminoncol.2014.06.006_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/labinvest.3700482","article-title":"Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion","volume":"86","author":"Zagzag","year":"2006","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4614-5915-6_12","article-title":"Imaging angiogenesis, inflammation, and metastasis in the tumor microenvironment with magnetic resonance imaging","volume":"772","author":"Serres","year":"2014","journal-title":"Adv Exp Med Biol"},{"issue":"3-4","key":"10.1053\/j.seminoncol.2014.06.006_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10555-012-9394-4","article-title":"The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies","volume":"31","author":"Fokas","year":"2012","journal-title":"Cancer Metast Rev"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/0008-5472.CAN-11-3406","article-title":"Anti-VEGF\/VEGFR therapy for cancer: reassessing the target","volume":"72","author":"Sitohy","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib16","first-page":"3","article-title":"Multimodal magnetic resonance imaging in the diagnosis and therapeutical follow-up of brain tumors","volume":"18","author":"Housni","year":"2013","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"issue":"Spec No 2","key":"10.1053\/j.seminoncol.2014.06.006_bib17","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1259\/bjr\/65711810","article-title":"Conventional MRI evaluation of gliomas","volume":"84","author":"Upadhyay","year":"2011","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2223010558","article-title":"High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging","volume":"222","author":"Law","year":"2002","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mric.2013.02.003","article-title":"Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging","volume":"21","author":"Brandao","year":"2013","journal-title":"Magn Reson Imag Clin North Am"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2009.92","article-title":"Quantitative imaging biomarkers in neuro-oncology","volume":"6","author":"Waldman","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2214\/AJR.12.9543","article-title":"Perfusion MRI: the five most frequently asked technical questions","volume":"200","author":"Essig","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib22","doi-asserted-by":"crossref","first-page":"W495","DOI":"10.2214\/AJR.12.9544","article-title":"Perfusion MRI: the five most frequently asked clinical questions","volume":"201","author":"Essig","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib23","series-title":"Basic radiology","author":"Chen","year":"2004"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.2003.05.063","article-title":"Cost of migration: invasion of malignant gliomas and implications for treatment","volume":"21","author":"Giese","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiology.166.3.2829270","article-title":"Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy","volume":"166","author":"Earnest","year":"1988","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib26","first-page":"777","article-title":"MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas","volume":"26","author":"Maia","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s003300050173","article-title":"Supratentorial diffuse astrocytic tumours: proposal of an MRI classification","volume":"7","author":"Pierallini","year":"1997","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.06.006_bib28","first-page":"2466","article-title":"MR imaging correlates of survival in patients with high-grade gliomas","volume":"26","author":"Pope","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.06.006_bib29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib30","first-page":"38","article-title":"Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas","volume":"8","author":"Shah","year":"2006","journal-title":"Neurooncology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib32","first-page":"156","article-title":"Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods","volume":"8","author":"Galanis","year":"2006","journal-title":"Neurooncology"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.06.006_bib33","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11910-009-0035-4","article-title":"Pseudoprogression and pseudoresponse: challenges in brain tumor imaging","volume":"9","author":"Clarke","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.WNL.0000133398.11870.9A","article-title":"Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression","volume":"63","author":"de Wit","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib36","first-page":"109","article-title":"MR Gd-DTPA enhancement of radiation brain injury","volume":"10","author":"Nishimura","year":"1992","journal-title":"Radiat Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.06.006_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ncponc1204","article-title":"Response criteria for glioma","volume":"5","author":"Sorensen","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib41","article-title":"Clinical applications of diffusion tensor imaging","author":"Lerner","year":"2013","journal-title":"World Neurosurg"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2014.06.006_bib42","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1148\/rg.26si065510","article-title":"Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond","volume":"26","author":"Hagmann","year":"2006","journal-title":"Radiographics"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib43","doi-asserted-by":"crossref","DOI":"10.3171\/2013.1.FOCUS12412","article-title":"Use of diffusion tensor imaging in glioma resection","volume":"34","author":"Abdullah","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib44","first-page":"937","article-title":"Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors","volume":"24","author":"Lu","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/nbm.1555","article-title":"Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo","volume":"24","author":"Byrnes","year":"2011","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroimage.2010.03.079","article-title":"DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma","volume":"52","author":"Giussani","year":"2010","journal-title":"NeuroImage"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib47","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/radiol.2353031338","article-title":"Apparent diffusion coefficient of human brain tumors at MR imaging","volume":"235","author":"Yamasaki","year":"2005","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1148\/radiol.2241010637","article-title":"Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics","volume":"224","author":"Guo","year":"2002","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3174\/ajnr.A0872","article-title":"Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging","volume":"29","author":"Toh","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib50","first-page":"1369","article-title":"Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging","volume":"23","author":"Lai","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2","article-title":"Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas","volume":"9","author":"Sugahara","year":"1999","journal-title":"J Magn Reson Imag JMRI"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2432060450","article-title":"Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging","volume":"243","author":"Murakami","year":"2007","journal-title":"Radiology"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1755-5949.2012.00354.x","article-title":"Axial diffusivity and tensor shape as early markers to assess cerebral white matter damage caused by brain tumors using quantitative diffusion tensor tractography","volume":"18","author":"Chen","year":"2012","journal-title":"CNS Neurosci Therapeut"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib54","first-page":"716","article-title":"Value of diffusion tensor imaging in differentiating high-grade from low-grade gliomas","volume":"96","author":"Piyapittayanan","year":"2013","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib55","first-page":"1081","article-title":"The role of diffusion-weighted imaging in patients with brain tumors","volume":"22","author":"Kono","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3174\/ajnr.A3315","article-title":"Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?","volume":"34","author":"Rose","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/crad.2001.0741","article-title":"Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?","volume":"57","author":"Lam","year":"2002","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib58","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiol.2413051276","article-title":"Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis","volume":"241","author":"Higano","year":"2006","journal-title":"Radiology"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00234-011-0947-y","article-title":"Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging","volume":"54","author":"Moon","year":"2012","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/cns.12.25","article-title":"Diffusion-weighted MRI as a biomarker for treatment response in glioma","volume":"1","author":"Schmainda","year":"2012","journal-title":"CNS Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejrad.2009.03.030","article-title":"Diffusion tensor magnetic resonance imaging of glial brain tumors","volume":"74","author":"Ferda","year":"2010","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-013-1049-y","article-title":"Glioma infiltration of the corpus callosum: early signs detected by DTI","volume":"112","author":"Kallenberg","year":"2013","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib63","first-page":"520","article-title":"Diffusion tensor MR imaging of high-grade cerebral gliomas","volume":"23","author":"Sinha","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib64","first-page":"356","article-title":"Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns","volume":"25","author":"Jellison","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"issue":"54","key":"10.1053\/j.seminoncol.2014.06.006_bib65","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1258\/ar.2012.120525","article-title":"Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy","volume":"2","author":"Nakamura","year":"2013","journal-title":"Acta Radiol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmri.20039","article-title":"Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume","volume":"19","author":"Oh","year":"2004","journal-title":"J Magn Reson Imag JMRI"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib67","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jmri.22304","article-title":"Predicting survival in glioblastomas using diffusion tensor imaging metrics","volume":"32","author":"Saksena","year":"2010","journal-title":"J Magn Reson Imag JMRI"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3174\/ajnr.A2385","article-title":"Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma","volume":"32","author":"Pope","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"10.1053\/j.seminoncol.2014.06.006_bib69","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00234-010-0731-4","article-title":"Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging","volume":"52","author":"Xu","year":"2010","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3171\/2012.12.JNS12125","article-title":"Postoperative ischemic changes following resection of newly diagnosed and recurrent gliomas and their clinical relevance","volume":"118","author":"Gempt","year":"2013","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-010-0293-7","article-title":"Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas","volume":"102","author":"Ellingson","year":"2011","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mric.2013.02.004","article-title":"Posttreatment evaluation of central nervous system gliomas","volume":"21","author":"Shiroishi","year":"2013","journal-title":"Magn Reson Imag Clin North Am"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.mric.2009.01.007","article-title":"Fundamentals of quantitative dynamic contrast-enhanced MR imaging","volume":"17","author":"Paldino","year":"2009","journal-title":"Magn Reson Imag Clin North Am"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib74","first-page":"186","article-title":"The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment","volume":"16","author":"Turkbey","year":"2010","journal-title":"Diagn Intervent Radiol (Ankara, Turkey)"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib75","series-title":"Quantitative MRI of the brain: measuring changes caused by disease","author":"Tofts","year":"2003"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib76","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/nbm.2994","article-title":"Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications","volume":"26","author":"Jain","year":"2013","journal-title":"NMR Biomed"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","article-title":"Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted MRI of a diffusable tracer: standardized quantities and symbols","volume":"10","author":"Tofts","year":"1999","journal-title":"J Magn Reson Imag"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib78","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/nbm.2994","article-title":"Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications","volume":"26","author":"Jain","year":"2013","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3171\/2013.9.JNS121924","article-title":"Using intraoperative dynamic contrast-enhanced T1-weighted MRI to identify residual tumor in glioblastoma surgery","volume":"120","author":"Ozduman","year":"2014","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jmri.23675","article-title":"Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas","volume":"36","author":"Zhang","year":"2012","journal-title":"J Magn Reson Imag JMRI"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib81","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3174\/ajnr.A3012","article-title":"Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas","volume":"33","author":"Nguyen","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.06.006_bib82","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0730-725X(00)00223-X","article-title":"Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging","volume":"18","author":"Ludemann","year":"2000","journal-title":"Magnetic Reson Imag"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1076-6332(03)80545-7","article-title":"Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors","volume":"8","author":"Roberts","year":"2001","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib84","first-page":"891","article-title":"Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade","volume":"21","author":"Roberts","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.06.006_bib85","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3760\/cma.j.issn.0366-6999.20111839","article-title":"Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade","volume":"126","author":"Jia","year":"2013","journal-title":"Chinese Med J"},{"issue":"17","key":"10.1053\/j.seminoncol.2014.06.006_bib86","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-4328","article-title":"The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas","volume":"66","author":"Cao","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib87","first-page":"853","article-title":"Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?","volume":"27","author":"Mills","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.acra.2011.01.018","article-title":"Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging","volume":"18","author":"Bisdas","year":"2011","journal-title":"Acad Radiol"},{"issue":"13","key":"10.1053\/j.seminoncol.2014.06.006_bib89","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-09-0814","article-title":"A \u201cvascular normalization index\u201d as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients","volume":"69","author":"Sorensen","year":"2009","journal-title":"Cancer Res"},{"issue":"18","key":"10.1053\/j.seminoncol.2014.06.006_bib90","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2005.07.144","article-title":"Use of magnetic resonance imaging to assess blood-brain\/blood-glioma barrier opening during conformal radiotherapy","volume":"23","author":"Cao","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib91","first-page":"1037","article-title":"Differentiating treatment-induced necrosis from recurrent\/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion","volume":"13","author":"Narang","year":"2011","journal-title":"Neurooncology"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib92","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3174\/ajnr.A1239","article-title":"Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma","volume":"30","author":"Young","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib93","first-page":"103","article-title":"Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis","volume":"15","author":"Halshtok Neiman","year":"2013","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib94","first-page":"2187","article-title":"Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors","volume":"26","author":"Bulakbasi","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib95","article-title":"Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","author":"Xing","year":"2013","journal-title":"Clin Neuroradiol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib96","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2214\/ajr.183.5.1831247","article-title":"Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI","volume":"183","author":"Holmes","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"982","key":"10.1053\/j.seminoncol.2014.06.006_bib97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1259\/bjr\/90100265","article-title":"Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging","volume":"82","author":"Chiang","year":"2009","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1053\/j.seminoncol.2014.06.006_bib98","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.wnl.0000219767.49705.9c","article-title":"Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors","volume":"66","author":"Weber","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiology.191.1.8134596","article-title":"Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings","volume":"191","author":"Aronen","year":"1994","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3174\/ajnr.A0851","article-title":"Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies","volume":"29","author":"Sadeghi","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3174\/ajnr.A1465","article-title":"Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?","volume":"30","author":"Bisdas","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib102","first-page":"214","article-title":"Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas","volume":"25","author":"Lev","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.06.006_bib103","first-page":"1989","article-title":"Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging","volume":"24","author":"Law","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib104","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cncr.20096","article-title":"Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors","volume":"100","author":"Tzika","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.2382042180","article-title":"Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging\u2014prediction of patient clinical response","volume":"238","author":"Law","year":"2006","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib106","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.2472070898","article-title":"Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"247","author":"Law","year":"2008","journal-title":"Radiology"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib107","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3174\/ajnr.A1121","article-title":"Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study","volume":"29","author":"Hirai","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/197140091302600404","article-title":"Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas","volume":"26","author":"Spampinato","year":"2013","journal-title":"Neuroradiol J"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1148\/radiol.2471062089","article-title":"Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?","volume":"247","author":"Danchaivijitr","year":"2008","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3174\/ajnr.A1377","volume":"30","author":"Hu","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib111","first-page":"416","article-title":"[Differentiation between glioma recurrence and radiation-induced brain injuries using perfusion-weighted magnetic resonance imaging]","volume":"35","author":"Wang","year":"2013","journal-title":"Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib112","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2532090007","article-title":"Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"253","author":"Barajas","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","article-title":"MRI perfusion in determining pseudoprogression in patients with glioblastoma","volume":"37","author":"Young","year":"2013","journal-title":"Clin Imag"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib114","first-page":"480","article-title":"Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme","volume":"15","author":"Lupo","year":"2013","journal-title":"Neurooncology"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib115","first-page":"442","article-title":"Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma","volume":"15","author":"LaViolette","year":"2013","journal-title":"Neurooncology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib116","first-page":"299","article-title":"Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy","volume":"81","author":"Roth","year":"1989","journal-title":"J Magn Reson"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib117","first-page":"44","article-title":"Regional in vivo proton magnetic resonance spectroscopy of brain","volume":"83","author":"Narayana","year":"1989","journal-title":"J Magn Reson"},{"issue":"Spec No A","key":"10.1053\/j.seminoncol.2014.06.006_bib118","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1102\/1470-7330.2009.9002","article-title":"Advanced imaging techniques in brain tumors","volume":"9","author":"Law","year":"2009","journal-title":"Cancer Imag"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.06.006_bib119","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3174\/ajnr.A0564","article-title":"Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema","volume":"28","author":"Ricci","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.06.006_bib120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00234-004-1246-7","article-title":"Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings","volume":"46","author":"Chiang","year":"2004","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/RCT.0b013e318282d2ba","article-title":"Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T","volume":"37","author":"Crisi","year":"2013","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib122","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3174\/ajnr.A1835","article-title":"In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases","volume":"31","author":"Pal","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib123","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(01)01548-6","article-title":"MR-spectroscopy guided target delineation for high-grade gliomas","volume":"50","author":"Pirzkall","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib124","first-page":"604","article-title":"Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens","volume":"22","author":"Dowling","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3171\/2013.1.JNS111561","article-title":"Intraoperative magnetic resonance spectroscopy for identification of residual tumor during low-grade glioma surgery: clinical article","volume":"118","author":"Pamir","year":"2013","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib126","first-page":"690","article-title":"1H-MR spectroscopy guided gamma knife radiosurgery for treatment of glioma","volume":"22","author":"Shen","year":"2012","journal-title":"Turkish Neurosurg"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/1522-2586(200101)13:1<12::AID-JMRI1002>3.0.CO;2-Q","article-title":"Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement","volume":"13","author":"Hall","year":"2001","journal-title":"J Magn Reson Imag JMRI"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000155232","article-title":"Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline","volume":"86","author":"Hermann","year":"2008","journal-title":"Stereotactic Function Neurosurg"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib129","first-page":"959","article-title":"Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy","volume":"22","author":"Martin","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clineuro.2012.11.002","article-title":"Potential of MR spectroscopy for assessment of glioma grading","volume":"115","author":"Bulik","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.06.006_bib131","first-page":"1404","article-title":"A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors","volume":"27","author":"Hollingworth","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib132","first-page":"367","article-title":"Effect of voxel position on single-voxel MR spectroscopy findings","volume":"21","author":"Ricci","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib133","first-page":"1645","article-title":"Correlation of myo-inositol levels and grading of cerebral astrocytomas","volume":"21","author":"Castillo","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib134","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11060-007-9508-y","article-title":"Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas","volume":"87","author":"Guillevin","year":"2008","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib135","first-page":"659","article-title":"Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas","volume":"21","author":"Shimizu","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/nbm.858","article-title":"Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas","volume":"17","author":"Li","year":"2004","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib137","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3174\/ajnr.A2251","article-title":"Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas","volume":"32","author":"Majos","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib138","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3171\/jns.1997.87.4.0516","article-title":"Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study","volume":"87","author":"Tedeschi","year":"1997","journal-title":"J Neurosurg"},{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib139","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.mri.2006.07.008","article-title":"Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions","volume":"24","author":"Sundgren","year":"2006","journal-title":"Magn Reson Imag"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/jns.1997.87.4.0525","article-title":"Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy","volume":"87","author":"Wald","year":"1997","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10014-006-0194-9","article-title":"Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases","volume":"23","author":"Chernov","year":"2006","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.06.006_bib142","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0360-3016(96)00376-8","article-title":"Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis","volume":"36","author":"Taylor","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib143","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1148\/radiol.2253010997","article-title":"In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience","volume":"225","author":"Rabinov","year":"2002","journal-title":"Radiology"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib144","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2214\/AJR.04.0933","article-title":"Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy","volume":"185","author":"Weybright","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib145","first-page":"613","article-title":"Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery","volume":"22","author":"Graves","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib146","doi-asserted-by":"crossref","first-page":"W45","DOI":"10.2214\/AJR.07.3934","article-title":"Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions","volume":"192","author":"Smith","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1053\/j.seminoncol.2014.06.006_bib147","doi-asserted-by":"crossref","first-page":"e56439","DOI":"10.1371\/journal.pone.0056439","article-title":"Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy","volume":"8","author":"Hattingen","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.06.006_bib148","first-page":"936","article-title":"Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625\/ACRIN 6677","volume":"15","author":"Ratai","year":"2013","journal-title":"Neurooncology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nic.2006.02.003","article-title":"Arterial spin labeling: benefits and pitfalls of high magnetic field","volume":"16","author":"Golay","year":"2006","journal-title":"Neuroimag Clin North Am"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib150","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jmri.24026","article-title":"Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas","volume":"38","author":"Yoo","year":"2013","journal-title":"J Magn Reson Imag JMRI"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib151","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00234-012-1089-6","article-title":"Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and (1)(8)F-fluorodeoxyglucose positron emission tomography","volume":"55","author":"Yamashita","year":"2013","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib152","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiol.2282020409","article-title":"Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging","volume":"228","author":"Warmuth","year":"2003","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.06.006_bib153","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000311520","article-title":"A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI","volume":"64","author":"Lehmann","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1053\/j.seminoncol.2014.06.006_bib154","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10334-011-0255-x","article-title":"Correlation between arterial blood volume obtained by arterial spin labelling and cerebral blood volume in intracranial tumours","volume":"24","author":"Van Westen","year":"2011","journal-title":"Magn Reson Mater Phy"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF00182486","article-title":"Noninvasive perfusion imaging of human brain tumors with EPISTAR","volume":"6","author":"Gaa","year":"1996","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1053\/j.seminoncol.2014.06.006_bib156","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3174\/ajnr.A0673","article-title":"Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas","volume":"28","author":"Chawla","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1053\/j.seminoncol.2014.06.006_bib157","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3174\/ajnr.A0903","article-title":"Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density","volume":"29","author":"Noguchi","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib158","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neurad.2007.11.007","article-title":"Pulsed arterial spin labeling applications in brain tumors: practical review","volume":"35","author":"Tourdias","year":"2008","journal-title":"J Neuroradiol"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.06.006_bib159","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1200\/JCO.2010.32.6082","article-title":"Early evaluation of tumoral response to antiangiogenic therapy by arterial spin labeling perfusion magnetic resonance imaging and susceptibility weighted imaging in a patient with recurrent glioblastoma receiving bevacizumab","volume":"29","author":"Fellah","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.06.006_bib160","first-page":"842","article-title":"Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma","volume":"11","author":"Pirzkall","year":"2009","journal-title":"Neurooncology"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.06.006_bib161","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-012-0997-y","article-title":"Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy","volume":"111","author":"Farace","year":"2013","journal-title":"J Neurooncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T01:07:15Z","timestamp":1716858435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775414001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":161,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0093775414001420"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.06.006","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}